Licensing Medicines: Consequences of the UK “Brexit" Vote to leave the European Union
Jefferys D.
RDD Europe 2017. Volume 1, 2017: 95-100.
Abstract:
This article summarizes the procedure that the United Kingdom will follow in exiting the European Union, the key issues facing the pharmaceutical and life science sector, and how these issues might be resolved. It also considers the impact on the UK and on the other 27 Member States.
I have a subscription
Log in for instant access.
I do not have a subscription
Purchase Article (in PDF format)
